Marcelo Capra
Impact in
- Hematology top 5%
- Multiple Myeloma Research and Treatments
-
- Peptidase Inhibition and Analysis
- Viral-associated cancers and disorders
Papers in
- Hematology 26
- Multiple Myeloma Research and Treatments 22
- Chronic Myeloid Leukemia Treatments 4
- Oncology 16
- Peptidase Inhibition and Analysis 7
- Viral-associated cancers and disorders 6
- Co-authors
- Meletios Α. Dimopoulos (15 shared papers)Aírton Tetelbom Stein (5 shared papers)Fernando Anschau (3 shared papers)Sandrine Macé (9 shared papers)Philippe Moreau (12 shared papers)Marie‐Laure Risse (9 shared papers)Craig E. Cole (2 shared papers)Vladimir Vorobyev (2 shared papers)
- Journals
- Blood (11 papers)Journal of Clinical Oncology (4 papers)HemaSphere (3 papers)Transplantation and Cellular Therapy (2 papers)Blood Advances (1 paper)
- Partner nations
- BrazilUnited StatesGreece
In The Last Decade
Marcelo Capra
36 papers receiving 330 citations
Peers
Comparison fields: 5 of 48
- Hematology 211
- Oncology 202
- Genetics 48
- Otorhinolaryngology 16
- Physiology 14
Countries citing papers authored by Marcelo Capra
This map shows the geographic impact of Marcelo Capra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcelo Capra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcelo Capra more than expected).
Fields of papers citing papers by Marcelo Capra
This network shows the impact of papers produced by Marcelo Capra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcelo Capra. The network helps show where Marcelo Capra may publish in the future.
Co-authors
The 25 scholars most cited alongside Marcelo Capra, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 50 | |
| 2 | 2019 | 44 | |
| 3 | 2023 | 25 | |
| 4 | 2018 | 24 | |
| 5 | 2020 | 23 | |
| 6 | 2021 | 19 | |
| 7 | 2021 | 18 | |
| 8 | 2012 | 16 | |
| 9 | 2018 | 16 | |
| 10 | 2022 | 14 | |
| 11 | 2023 | 11 | |
| 12 | 2017 | 10 | |
| 13 | 2020 | 9 | |
| 14 | 2017 | 7 | |
| 15 | 2016 | 7 | |
| 16 | 2020 | 6 | |
| 17 | 2009 | 5 | |
| 18 | 2020 | 4 | |
| 19 | 2024 | 3 | |
| 20 | 2021 | 2 |
About Marcelo Capra
Marcelo Capra is a scholar working on Hematology, Oncology, Pathology and Forensic Medicine, Molecular Biology and Genetics, having authored 40 papers that have together received 336 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (22 papers), Chronic Lymphocytic Leukemia Research (7 papers), Lymphoma Diagnosis and Treatment (7 papers), Peptidase Inhibition and Analysis (7 papers), Viral-associated cancers and disorders (6 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), Chronic Myeloid Leukemia Treatments (4 papers) and Cancer Mechanisms and Therapy (4 papers). The work is most often cited by research in Hematology (211 citations), Oncology (202 citations), Genetics (48 citations), Otorhinolaryngology (16 citations) and Physiology (14 citations). Marcelo Capra has collaborated with scholars based in Brazil, United States and Greece. Frequent co-authors include Meletios Α. Dimopoulos, Aírton Tetelbom Stein, Fernando Anschau, Sandrine Macé, Philippe Moreau, Marie‐Laure Risse, Craig E. Cole, Vladimir Vorobyev, Eduardo Yañez Ruiz and Thierry Façon. Their work appears in journals such as Blood, Journal of Clinical Oncology, HemaSphere, Transplantation and Cellular Therapy and Blood Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.